Commercialization: Page 45
-
PharmaVoice Team/PharmaVoice
Talent Pool
Executive appointments and promotions in the healthcare industry Pharma Pool Stephen Aselage Retrophin Appoints CEO Retrophin has appointed Stephen Aselage as CEO; he has served as the company’s interim CEO since Sept. 30, 2014. Mr. Aselage has more than 30 years of pharmaceutical and biotechnolo...
By PharmaVoice Team • Jan. 1, 2015 -
PharmaVoice Team/PharmaVoice
Where Have All The Sales Reps Gone?
The death of the pharma sales rep has been greatly exaggerated, however, the role of the sales rep is headed for big changes. Healthcare providers are choosing multiple channels to receive their information on pharma products, which could lead to the assumption that pharma sales reps could soon b...
By Robin Robinson • Jan. 1, 2015 -
PharmaVoice Team/PharmaVoice
Using Consumer Data In R&D
Consumer and personal health data will play a larger role in clinical research in the future. More and more data relevant to health are being captured by consumers and patients through patient diaries, monitoring devices, and health and fitness tracking diaries, and apps. Patient and consumer dat...
By Denise Myshko • Jan. 1, 2015 -
PharmaVoice Team/PharmaVoice
Track And Trace: Preparing For DSCSA Implementation
The first deadline of the 10-year DSCSA Implementation Plan takes effect this month, and experts say many drug manufacturers are not ready. The Drug Supply Chain Security Act (DSCSA) Implementation Plan regulation, which began phasing in on Jan. 1, 2015, provides a national policy for combating c...
By Robin Robinson • Jan. 1, 2015 -
PharmaVoice Team/PharmaVoice
South Korea
Proven R&D capabilities, a strong regulatory system, government support, and a wealth of talent are among the factors that draw pharma companies to South Korea. South Korea, or the Republic of Korea, is an industrialized nation with a strong standing on the world stage. It was the first Asian...
By Kim Ribbink • Jan. 1, 2015 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: Social Media: A Social Revolution
As pharmaceutical companies continue to dabble in social media, patients and consumers are not waiting, and are in fact, driving health-related conversations in a variety of ways and across a variety of media, most importantly digital. A recent study found that one-quarter of the world’s populati...
By Taren Grom • Jan. 1, 2015 -
PharmaVoice Team/PharmaVoice
Making Better Connections With Context
Our involvement in social media requires thoughtful planning; predetermined and approved frameworks; rules of engagement, content workflows, and efficient approval workflows; monitoring technologies; legal guidelines; and integrated QA processes. My job, probably yours too, is to connect HCPs a...
By Ben Currie • Jan. 1, 2015 -
PharmaVoice Team/PharmaVoice
Making Social Count: How Mobile and Data Help Social Media Reach Their Potential
For years, pharmaceutical marketers have talked about moving “beyond the pill." We know our work needs to provide patients with tools and services to help manage and improve their health, in concert with — or even instead of — our prescription brands. We’ve exhorted each other to not be satisfie...
By Sarah Morgan • Jan. 1, 2015 -
PharmaVoice Team/PharmaVoice
Social Media Has Revolutionized The Healthcare Industry
The marketing function of the pharmaceutical industry needs to begin focusing on changing its thinking around social media, to more of an -engagement-oriented model and less around advertising and promotion. Social should be viewed as an integral part of the overall marketing mix and not silo’d o...
By Ritesh Patel • Jan. 1, 2015 -
PharmaVoice Team/PharmaVoice
Detangling Oncology
Oncology is expected to be the biggest therapeutic class by 2017. In this first article in an ongoing series addressing various aspects involved with oncology, experts examine the market drivers, research highlights, and marketing, sales, and payer considerations of this market. In 2014, there we...
By PharmaVoice Team • Jan. 1, 2015 -
PharmaVoice Team/PharmaVoice
Disruptive Technology: The Keys to Pharmaceutical Innovation
New technologies will drive innovation in the pharmaceutical industry in the years to come. The ability to innovate, industry leaders agree, will be a critical factor in a pharmaceutical company’s success in the future. Companies will have to embrace scientific advances and technologies to move n...
By PharmaVoice Team • Nov. 15, 2014 -
PharmaVoice Team/PharmaVoice
Personalized Medicine: Personalized Medicine Gains Momentum
Personalized and precision medicines have the potential to change the way we think about, identify, and manage healthcare. In the years since the completion of the Human Genome Project, advances in genome technology have led to an exponential decrease in sequencing costs. This has led to more tha...
By PharmaVoice Team • Nov. 15, 2014 -
PharmaVoice Team/PharmaVoice
Payers: Addressing the Needs of Payers
Helping payers contain costs and improve outcomes becomes paramount for pharma in the healthcare reform future. According to an EY report, the majority of payers in the United States and Europe believe that drug adherence solutions and data that pharma companies possess are vital to lowering heal...
By PharmaVoice Team • Nov. 15, 2014 -
PharmaVoice Team/PharmaVoice
Patient-Centricity: The Power of the Patient
As patients move from recipients to participants, the industry needs to align strategies to pull them into the focus of future business models. A recent PwC report describes a new health economy on the horizon, one in which technological advances, empowered consumers, disruptive new entrants, and...
By PharmaVoice Team • Nov. 15, 2014 -
PharmaVoice Team/PharmaVoice
Specialty Pharma: Specialty Pharma on the Rise
v According to Express Scripts, more than one-third of all specialty drugs currently in development — and there are nearly 900 of them — target cancer and related conditions, which is by far the most concentrated area of research. But specialty drugs manage many other complex, chronic conditions,...
By PharmaVoice Team • Nov. 15, 2014 -
PharmaVoice Team/PharmaVoice
R&D Crowdsourcing: Crowdsourcing in Pharma
Companies are looking at nontraditional ways of collaborating to access new insights that could lead to innovative therapies. There is a growing movement within the industry toward open access and crowdsourcing scientific information to accelerate research and development. This open environment r...
By Denise Myshko • Nov. 15, 2014 -
PharmaVoice Team/PharmaVoice
Augmented Reality: An Overlap Between the Virtual and the Real World
Augmented reality can take technology to a new level to improve patient outcomes and the healthcare journey. Augmented reality, the technology originally popularized as part of simulators and virtual reality games more than a decade ago, is gaining traction today in the pharma space. AR is relate...
By Taren Grom • Nov. 15, 2014 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: E-Solutions: Power Surge
E-Solutions ranging from mobile advances to EMR technologies are expected to reframe the patient model. Notably, the most encouraging news on mobile and quantified health is the recent announcement and launch of the HealthKit platform and the mobile app Health by Apple. HealthKit allows devices a...
By Taren Grom • Nov. 15, 2014 -
PharmaVoice Team/PharmaVoice
The Power of the Patient: The Era of Healthcare Consumerism
The step-change towards healthcare consumerism means that healthcare providers are increasingly targeting their products towards patients to help them become more engaged in their own healthcare decision-making along their journey as a patient, focusing on quality and convenience. With this in mi...
By Tim Davis • Nov. 15, 2014 -
PharmaVoice Team/PharmaVoice
Powering Up eSolutions to Improve Healthcare
Use of data-powered eSolutions will rapidly increase as HCPs become more aware of their benefits and more strongly motivated to test the waters and experience these tools firsthand. Healthcare is continuing its major shift toward “accountable care" — a move based on anticipated resulting improve...
By Rick Vaughan • Nov. 15, 2014 -
PharmaVoice Team/PharmaVoice
Healthcare Storytelling Delivery: In the Digital Age
If you represent a brand, you must tell a story about the features and benefits of your project, so that your target user can make sense of it. Yesterday, a woman named Sharon dragged herself out of bed and shuffled to the shower. She turned on the water and massaged shampoo into her hair. And as...
By Buddy Scalera • Nov. 15, 2014 -
PharmaVoice Team/PharmaVoice
The Future of Healthcare is Wearable
EHR is connecting our healthcare, the Internet of things is connecting our world, and now wearables are connecting everything else. With health data becoming increasingly more standardized and accessible, there is a future where healthcare is personalized not just to our health, but also to our l...
By Matt Balogh • Nov. 15, 2014 -
PharmaVoice Team/PharmaVoice
E-Solutions as Part of a Multi-channel Strategy: An Integrated Approach to Reach the Physician
Integrated channel management offers an approach to combine e-solutions and traditional channels into a customized and cost-effective communications and optimization mix. With ever-increasing competition for healthcare providers’ time, attention, and the escalating challenge of access, the tradit...
By Peter Dussias • Nov. 15, 2014 -
PharmaVoice Team/PharmaVoice
Digital Solutions: A New Interface
We need to turn the discussion away from digital solutions, data strategy, or traditional channels and realize that it is all channels of interaction. The relationship between digital and traditional are not independent with one succeeding over another, but interdependent with both supporting the...
By Jeremy Shubert • Nov. 15, 2014 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
2015 and beyond… This is the time of year when we all take a moment to reflect on the events of the past year and what lies ahead. In 2014, the industry went through a burst of deals between several major players — Novartis, Eli Lilly and Company, and GlaxoSmithKline — as they look to refocus on ...
By Taren Grom • Nov. 15, 2014
Previous
